BZBenshan Zhang

Benshan Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects


Benshan Zhang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Chenlu Liu

    Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College 1 State Key Laboratory of Common Mechanism Research for Major Diseases Beijing

    1 shared publication
  • Fei Liu

    Department of Nephrology, The Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China

    1 shared publication
  • Jianhua Mao

    Department of Nephrology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children’s Regional Medical Center, Hangzhou, China

    1 shared publication
  • Li Guo

    Department of Rheumatology Immunology and Allergy Children's Hospital, Zhejiang University School of Medicine Hangzhou China

    1 shared publication
  • Liang Zhang

    The Affiliated Children’s Hospital of Xiangya School of Medicine, Central South University (Hunan children’s hospital)

    1 shared publication
  • Meiping Lu

    Department of Rheumatology Immunology & Allergy, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, PR China

    1 shared publication

Latest Publications

  • Open Access

    Deficiency of NBAS causes immune dysregulation due to hyperactivation of IFN signaling

    by Chenlu Liu, Liang Zhang, Meiping Lu, Yunyan Shen, Yuhao Yao, Fei Liu, Qintao Wang, Benshan Zhang, Li Guo, Xiaozhong Li, et al.

    NBAS deficiency is a multisystem disorder, but its immunologic manifestations and underlying mechanisms remain poorly defined. Here, we expand the genotypic and phenotypic spectrum of NBAS deficiency through four patients carrying five loss-of-function NBAS mutations. Minigene assays and RNA analysis showed that these splicing or missense mutations resulted in aberrant alternative splicing. Clinically, the patients showed early-onset recurrent or persistent cytopenias and immune dysregulation, together with severe infections, inflammatory activation, and multi-organ involvement, including renal and neurologic manifestations. Transcriptomic analysis revealed overactivation of type I interferon signaling pathways compared with healthy controls, and single-cell RNA sequencing demonstrated that this upregulated inflammation was predominantly driven by myeloid cells. Together, these findings identify NBAS deficiency as a cause of immune dysregulation characterized by myeloid-driven type I interferonopathy, expand the clinical spectrum of NBAS-related disorders, and highlight the critical role of NBAS in maintaining immune homeostasis.